Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 924.22 Million USD | 12.37% |
| 2023 | 822.44 Million USD | 56.01% |
| 2022 | 527.15 Million USD | 12.53% |
| 2021 | 468.45 Million USD | 12.03% |
| 2020 | 418.17 Million USD | 0.96% |
| 2019 | 414.18 Million USD | 2.97% |
| 2018 | 402.25 Million USD | 11.24% |
| 2017 | 361.59 Million USD | 12.55% |
| 2016 | 321.27 Million USD | 13.5% |
| 2015 | 283.07 Million USD | 14.42% |
| 2014 | 247.4 Million USD | 19.22% |
| 2013 | 207.52 Million USD | 12.76% |
| 2012 | 184.04 Million USD | 6.58% |
| 2011 | 172.68 Million USD | 22.9% |
| 2010 | 140.5 Million USD | 18.35% |
| 2009 | 118.72 Million USD | 15.92% |
| 2008 | 102.41 Million USD | 18.9% |
| 2007 | 86.13 Million USD | 18.92% |
| 2006 | 72.43 Million USD | 15.42% |
| 2005 | 62.75 Million USD | 13.08% |
| 2004 | 55.49 Million USD | 19.38% |
| 2003 | 46.48 Million USD | 13.12% |
| 2002 | 41.09 Million USD | 17.77% |
| 2001 | 34.89 Million USD | 48.41% |
| 2000 | 23.51 Million USD | 5.91% |
| 1999 | 22.2 Million USD | 20.0% |
| 1998 | 18.5 Million USD | 20.92% |
| 1997 | 15.3 Million USD | 22.4% |
| 1996 | 12.5 Million USD | 6.84% |
| 1995 | 11.7 Million USD | 9.35% |
| 1994 | 10.7 Million USD | 40.79% |
| 1993 | 7.6 Million USD | 15.15% |
| 1992 | 6.6 Million USD | 10.0% |
| 1991 | 6 Million USD | 0.0% |
| 1990 | 6 Million USD | -3.23% |
| 1989 | 6.2 Million USD | 29.17% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 228.81 Million USD | -0.36% |
| 2024 Q2 | 229.62 Million USD | 0.28% |
| 2024 Q4 | 236.79 Million USD | 3.49% |
| 2024 Q1 | 228.98 Million USD | -5.3% |
| 2024 FY | 924.22 Million USD | 12.37% |
| 2023 Q1 | 132.34 Million USD | -5.53% |
| 2023 Q2 | 230.03 Million USD | 73.81% |
| 2023 FY | 822.44 Million USD | 56.01% |
| 2023 Q3 | 218.25 Million USD | -5.12% |
| 2023 Q4 | 241.81 Million USD | 10.79% |
| 2022 Q3 | 128.24 Million USD | -1.74% |
| 2022 Q1 | 128.3 Million USD | 0.69% |
| 2022 Q4 | 140.09 Million USD | 9.24% |
| 2022 FY | 527.15 Million USD | 12.53% |
| 2022 Q2 | 130.51 Million USD | 1.72% |
| 2021 Q3 | 116.7 Million USD | 1.49% |
| 2021 FY | 468.45 Million USD | 12.03% |
| 2021 Q4 | 127.42 Million USD | 9.18% |
| 2021 Q2 | 115 Million USD | 5.19% |
| 2021 Q1 | 109.32 Million USD | 0.23% |
| 2020 Q4 | 109.07 Million USD | 9.22% |
| 2020 FY | 418.17 Million USD | 0.96% |
| 2020 Q1 | 101.42 Million USD | -7.6% |
| 2020 Q2 | 107.8 Million USD | 6.29% |
| 2020 Q3 | 99.86 Million USD | -7.36% |
| 2019 Q2 | 107.09 Million USD | 7.5% |
| 2019 Q1 | 99.62 Million USD | -8.84% |
| 2019 Q4 | 109.76 Million USD | 12.35% |
| 2019 Q3 | 97.7 Million USD | -8.78% |
| 2019 FY | 414.18 Million USD | 2.97% |
| 2018 Q1 | 95.25 Million USD | -3.63% |
| 2018 Q4 | 109.28 Million USD | 13.97% |
| 2018 Q3 | 95.89 Million USD | -5.82% |
| 2018 Q2 | 101.81 Million USD | 6.89% |
| 2018 FY | 402.25 Million USD | 11.24% |
| 2017 Q2 | 90.71 Million USD | 8.45% |
| 2017 FY | 361.59 Million USD | 12.55% |
| 2017 Q3 | 88.38 Million USD | -2.57% |
| 2017 Q4 | 98.84 Million USD | 11.84% |
| 2017 Q1 | 83.64 Million USD | -7.14% |
| 2016 FY | 321.27 Million USD | 13.5% |
| 2016 Q4 | 90.07 Million USD | 17.41% |
| 2016 Q1 | 74.86 Million USD | -4.77% |
| 2016 Q2 | 79.61 Million USD | 6.35% |
| 2016 Q3 | 76.72 Million USD | -3.62% |
| 2015 FY | 283.07 Million USD | 14.42% |
| 2015 Q4 | 78.61 Million USD | 14.91% |
| 2015 Q2 | 68.45 Million USD | 1.27% |
| 2015 Q3 | 68.4 Million USD | -0.07% |
| 2015 Q1 | 67.59 Million USD | 0.5% |
| 2014 Q3 | 61.99 Million USD | 4.02% |
| 2014 FY | 247.4 Million USD | 19.22% |
| 2014 Q1 | 58.54 Million USD | 4.54% |
| 2014 Q2 | 59.59 Million USD | 1.8% |
| 2014 Q4 | 67.26 Million USD | 8.49% |
| 2013 Q2 | 50.73 Million USD | 2.03% |
| 2013 Q4 | 56 Million USD | 9.7% |
| 2013 FY | 207.52 Million USD | 12.76% |
| 2013 Q1 | 49.72 Million USD | 2.44% |
| 2013 Q3 | 51.05 Million USD | 0.63% |
| 2012 Q2 | 44.89 Million USD | -1.76% |
| 2012 FY | 184.04 Million USD | 6.58% |
| 2012 Q4 | 48.54 Million USD | 8.09% |
| 2012 Q3 | 44.91 Million USD | 0.05% |
| 2012 Q1 | 45.69 Million USD | 4.82% |
| 2011 Q1 | 42.92 Million USD | 9.84% |
| 2011 Q2 | 43.93 Million USD | 2.35% |
| 2011 Q3 | 42.23 Million USD | -3.86% |
| 2011 Q4 | 43.59 Million USD | 3.22% |
| 2011 FY | 172.68 Million USD | 22.9% |
| 2010 Q4 | 39.07 Million USD | 15.51% |
| 2010 Q1 | 32.34 Million USD | 4.72% |
| 2010 Q2 | 35.25 Million USD | 8.98% |
| 2010 Q3 | 33.83 Million USD | -4.03% |
| 2010 FY | 140.5 Million USD | 18.35% |
| 2009 Q1 | 28.8 Million USD | 6.22% |
| 2009 FY | 118.72 Million USD | 15.92% |
| 2009 Q2 | 31.18 Million USD | 8.27% |
| 2009 Q3 | 27.84 Million USD | -10.73% |
| 2009 Q4 | 30.89 Million USD | 10.96% |
| 2008 Q3 | 25.18 Million USD | -7.46% |
| 2008 Q4 | 27.11 Million USD | 7.7% |
| 2008 FY | 102.41 Million USD | 18.9% |
| 2008 Q1 | 22.9 Million USD | 1.03% |
| 2008 Q2 | 27.21 Million USD | 18.77% |
| 2007 FY | 86.13 Million USD | 18.92% |
| 2007 Q4 | 22.67 Million USD | 7.7% |
| 2007 Q3 | 21.05 Million USD | -5.12% |
| 2007 Q2 | 22.18 Million USD | 9.74% |
| 2007 Q1 | 20.22 Million USD | 2.04% |
| 2006 Q1 | 16.77 Million USD | 4.81% |
| 2006 Q2 | 18.25 Million USD | 8.81% |
| 2006 Q3 | 17.58 Million USD | -3.69% |
| 2006 Q4 | 19.81 Million USD | 12.7% |
| 2006 FY | 72.43 Million USD | 15.42% |
| 2005 Q4 | 16 Million USD | 11.14% |
| 2005 Q3 | 14.4 Million USD | -15.93% |
| 2005 Q2 | 17.13 Million USD | 12.63% |
| 2005 Q1 | 15.21 Million USD | -0.59% |
| 2005 FY | 62.75 Million USD | 13.08% |
| 2004 Q1 | 12.23 Million USD | 0.14% |
| 2004 FY | 55.49 Million USD | 19.38% |
| 2004 Q4 | 15.3 Million USD | 3.97% |
| 2004 Q3 | 14.71 Million USD | 11.11% |
| 2004 Q2 | 13.24 Million USD | 8.28% |
| 2003 Q1 | 10.89 Million USD | -1.04% |
| 2003 Q2 | 12.27 Million USD | 12.63% |
| 2003 Q3 | 11.1 Million USD | -9.54% |
| 2003 Q4 | 12.21 Million USD | 10.03% |
| 2003 FY | 46.48 Million USD | 13.12% |
| 2002 Q1 | 9.73 Million USD | 6.23% |
| 2002 Q3 | 9.65 Million USD | -9.76% |
| 2002 Q4 | 11.01 Million USD | 14.05% |
| 2002 Q2 | 10.69 Million USD | 9.94% |
| 2002 FY | 41.09 Million USD | 17.77% |
| 2001 Q1 | 8.12 Million USD | 25.56% |
| 2001 Q2 | 9 Million USD | 10.89% |
| 2001 Q3 | 8.6 Million USD | -4.53% |
| 2001 Q4 | 9.16 Million USD | 6.51% |
| 2001 FY | 34.89 Million USD | 48.41% |
| 2000 Q1 | 5.3 Million USD | 0.0% |
| 2000 FY | 23.51 Million USD | 5.91% |
| 2000 Q4 | 6.47 Million USD | 3.09% |
| 2000 Q3 | 6.27 Million USD | 16.22% |
| 2000 Q2 | 5.4 Million USD | 1.89% |
| 1999 Q3 | 5.3 Million USD | -10.17% |
| 1999 FY | 22.2 Million USD | 20.0% |
| 1999 Q1 | 5.7 Million USD | 16.33% |
| 1999 Q2 | 5.9 Million USD | 3.51% |
| 1999 Q4 | 5.3 Million USD | 0.0% |
| 1998 Q3 | 4.5 Million USD | -2.17% |
| 1998 Q4 | 4.9 Million USD | 8.89% |
| 1998 FY | 18.5 Million USD | 20.92% |
| 1998 Q2 | 4.6 Million USD | 4.55% |
| 1998 Q1 | 4.4 Million USD | 12.82% |
| 1997 Q2 | 3.8 Million USD | -5.0% |
| 1997 FY | 15.3 Million USD | 22.4% |
| 1997 Q4 | 3.9 Million USD | 8.33% |
| 1997 Q1 | 4 Million USD | 33.33% |
| 1997 Q3 | 3.6 Million USD | -5.26% |
| 1996 Q4 | 3 Million USD | -9.09% |
| 1996 FY | 12.5 Million USD | 6.84% |
| 1996 Q3 | 3.3 Million USD | 3.13% |
| 1996 Q2 | 3.2 Million USD | 10.34% |
| 1996 Q1 | 2.9 Million USD | -6.45% |
| 1995 Q1 | 2.6 Million USD | -3.7% |
| 1995 Q2 | 2.9 Million USD | 11.54% |
| 1995 Q3 | 3 Million USD | 3.45% |
| 1995 FY | 11.7 Million USD | 9.35% |
| 1995 Q4 | 3.1 Million USD | 3.33% |
| 1994 FY | 10.7 Million USD | 40.79% |
| 1994 Q2 | 3 Million USD | 36.36% |
| 1994 Q3 | 2.7 Million USD | -10.0% |
| 1994 Q4 | 2.7 Million USD | 0.0% |
| 1994 Q1 | 2.2 Million USD | 0.0% |
| 1993 FY | 7.6 Million USD | 15.15% |
| 1993 Q4 | 2.2 Million USD | 4.76% |
| 1993 Q3 | 2.1 Million USD | 10.53% |
| 1993 Q2 | 1.9 Million USD | 26.67% |
| 1993 Q1 | 1.5 Million USD | -16.67% |
| 1992 Q4 | 1.8 Million USD | 0.0% |
| 1992 FY | 6.6 Million USD | 10.0% |
| 1992 Q3 | 1.8 Million USD | 5.88% |
| 1992 Q2 | 1.7 Million USD | 30.77% |
| 1992 Q1 | 1.3 Million USD | -31.58% |
| 1991 Q2 | 1.5 Million USD | 36.36% |
| 1991 Q3 | 1.5 Million USD | 0.0% |
| 1991 FY | 6 Million USD | 0.0% |
| 1991 Q4 | 1.9 Million USD | 26.67% |
| 1991 Q1 | 1.1 Million USD | -31.25% |
| 1990 Q1 | 1.2 Million USD | -25.0% |
| 1990 Q3 | 1.4 Million USD | -12.5% |
| 1990 Q2 | 1.6 Million USD | 33.33% |
| 1990 Q4 | 1.6 Million USD | 14.29% |
| 1990 FY | 6 Million USD | -3.23% |
| 1989 Q3 | 1.5 Million USD | -6.25% |
| 1989 FY | 6.2 Million USD | 29.17% |
| 1989 Q4 | 1.6 Million USD | 6.67% |
| 1989 Q1 | 1.5 Million USD | 25.0% |
| 1989 Q2 | 1.6 Million USD | 6.67% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bionano Genomics, Inc. | 36.11 Million USD | -2459.038% |
| Prenetics Global Limited | 21.74 Million USD | -4150.728% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -1918.613% |
| CareDx, Inc | 280.32 Million USD | -229.698% |
| Exact Sciences Corporation | 2.49 Billion USD | 63.028% |
| Exagen Inc. | 52.54 Million USD | -1658.815% |
| Inotiv, Inc. | 572.42 Million USD | -61.457% |
| Guardant Health, Inc. | 563.94 Million USD | -63.884% |
| Biodesix, Inc. | 49.08 Million USD | -1782.824% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -9359.015% |
| Precipio, Inc. | 15.19 Million USD | -5981.608% |
| iSpecimen Inc. | 9.92 Million USD | -9209.074% |
| Natera, Inc. | 1.08 Billion USD | 14.627% |
| Aspira Women's Health Inc. | 9.15 Million USD | -9996.373% |
| Standard BioTools Inc. | 106.34 Million USD | -769.12% |
| 23andMe Holding Co. | 219.63 Million USD | -320.793% |
| Castle Biosciences, Inc. | 219.78 Million USD | -320.506% |
| Personalis, Inc. | 73.48 Million USD | -1157.77% |
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -2857.605% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -6813.977% |
| OpGen, Inc. | 3.41 Million USD | -26937.317% |
| T2 Biosystems, Inc. | 7.19 Million USD | -12748.909% |
| Myriad Genetics, Inc. | 678.4 Million USD | -36.236% |
| ICON Public Limited Company | 8.12 Billion USD | 88.618% |
| NeoGenomics, Inc. | 591.64 Million USD | -56.213% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -1918.613% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 74.755% |
| RadNet, Inc. | 1.61 Billion USD | 42.83% |
| MDxHealth SA | 70.19 Million USD | -1216.687% |
| Psychemedics Corporation | 22.09 Million USD | -4082.378% |
| Illumina, Inc. | 4.5 Billion USD | 79.48% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 312.97 Million USD | -195.303% |
| DarioHealth Corp. | 20.35 Million USD | -4441.185% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -219.564% |
| Sera Prognostics, Inc. | 306 Thousand USD | -301933.333% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 863.49 Million USD | -7.033% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 50.992% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -29600.741% |
| Prenetics Global Limited | 21.74 Million USD | -4150.728% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -103109.791% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -36394.467% |
| Trinity Biotech plc | 56.83 Million USD | -1526.235% |
| Neuronetics, Inc. | 71.34 Million USD | -1195.372% |
| Sotera Health Company | 1.04 Billion USD | 11.919% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -36394.467% |